Cluster 3 had high expression of these genes, such as NOD2 and IL18, and high PScore (Additional file 1: Fig. S4D), but according to survival analysis, this model based on metastatic melanoma patients may not be suitable for primary melanoma patients (Additional file 1: Fig. S4E). This evidence concerns the gene IL18 and melanoma.